Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed
Abstract In the 1980s, a global number of 72 fatalities were reported in the UK and the USA following the application of subcutaneous immunotherapy (SCIT). This resulted in a significant limitation of SCIT use and in the search of other routes of administration, among which sublingual immunotherapy...
Main Authors: | Ralph Mösges, Desiderio Passali, Mario Di Gioacchino |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Clinical and Translational Allergy |
Online Access: | https://doi.org/10.1002/clt2.12012 |
Similar Items
-
Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis
by: Makoto Hoshino, et al.
Published: (2022-10-01) -
Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet
by: Minoru Gotoh, et al.
Published: (2020-01-01) -
Stability evaluation of house dust mite vaccines for sublingual immunotherapy
by: MARIJA GAVROVIĆ-JANKULOVIĆ, et al.
Published: (2010-01-01) -
House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice
by: Žana Tempels-Pavlica, et al.
Published: (2024-02-01) -
Sublingual Immunotherapy with House Dust Extract for House Dust-Mite Allergic Rhinitis in Children
by: Syuji Yonekura, et al.
Published: (2010-01-01)